Trends in Immunotherapy

Trends in Immunotherapy (TI) is an open access, peer-reviewed journal encompassing various disciplines related to all immune-based areas. TI has a target audience consisting of scientific researchers, professional practitioners and medical scholars from academia, medical industry, and education, etc. It provides a forum to share scholarly practice to advance the immunotherapy in the combination of science and medicine.

TI publishes original research articles, review articles, editorials, mini-review articles, case reports, commentaries, correspondence articles, database articles, perspective articles, short reports, etc. Preliminary studies, pre-clinical and clinical investigative reports are welcomed.

The research topics of TI include but are not limited to:

1. Cancer immunotherapy 8. Efficacy of drug immunotherapy
2. Targeted therapy and tumor microenvironment9. Allergy disorder and immunotherapy
3. Immune dysregulation, skin barrier dysfunction10. Immunotherapy cell-products
4. Chemoimmunotherapy 11. Immuno-modulatory effects of natural products
5. Antibodies 12. Vaccine development and application
6. Immunomodulators, inhibitors and intensifiers  13. Cytokines application
7. Therapeutic method for auto-immune disorder  14. Wound healing

            2573-5985 (Online)

 

 

Online Submissions

Already have a Username/Password for Trends in Immunotherapy?
GO TO LOGIN

Need a Username/Password?
GO TO REGISTRATION

Registration and login are required to submit items online and to check the status of current submissions.

 

Submission Preparation Checklist

As part of the submission process, authors are required to check off their submission's compliance with all of the following items, and submissions may be returned to authors that do not adhere to these guidelines.

  1. The submission has not been previously published, nor is it before another journal for consideration (or an explanation has been provided in Comments to the Editor).
  2. The submission file is in Microsoft Word format.
  3. Where available, URLs for the references have been provided.
  4. The text adheres to the stylistic and bibliographic requirements outlined in the Author Guidelines, which is found in About the Journal.
  5. If submitting to a peer-reviewed section of the journal, the instructions in Ensuring a Blind Review have been followed.
 

Recently Published

Case report

Mami Ishibashi, Yoshihiro Ishida, Atsushi Otsuka, Shuji Yamamoto, Kenji Kabashima
View: PDF

Case report

Tatsuya Yamashita, Toshio Ohtani
View: Abstract | PDF

Review article

Fukumi Furukawa
View: Abstract | PDF

Mini-review

Motonobu Nakamura
View: Abstract | PDF

Case report

Mami Ishibashi, Reiko Koga, Eriko Adachi, Yuna Yamagami, Masami Ichinona, Yoshiaki Yoshikawa
View: Abstract | PDF

Case report

Shoya Yano, Aika Okuno, Fukumi Furukawa
View: PDF
 

Commentary

Fukumi Furukawa
View: PDF
 
 

Announcements

 

Perspective on allergen immunotherapy

In recent years, there have been attempts to improve the safety and convenience for patients whilst retaining efficacy of allergen immunotherapy. These include the use of modified allergens (known as allergoids) and alternative routes of immunotherapy.
Posted: 2022-10-29 More...
 
More Announcements...